4

αποτέλεσμα(ατα)

Λέξη (-εις)
Τύπος δημοσίευσης
Τομέας πολιτικής
Συντάκτης
Ημερομηνία

Cleaner air for Europe: EU efforts to fight air pollution

23-06-2017

Air pollution knows no borders. Wind can carry pollutants over thousands of kilometres. Poor air quality impacts negatively on human health, ecosystems, crop yields and buildings. It is one of the main environmental causes of premature death, having claimed 5.5 million lives globally and over 430 000 in the EU in 2013. The European Commission estimates the cost of air pollution linked to the degradation of health in European society to amount to €330 billion to €940 billion per year. Developed since ...

Air pollution knows no borders. Wind can carry pollutants over thousands of kilometres. Poor air quality impacts negatively on human health, ecosystems, crop yields and buildings. It is one of the main environmental causes of premature death, having claimed 5.5 million lives globally and over 430 000 in the EU in 2013. The European Commission estimates the cost of air pollution linked to the degradation of health in European society to amount to €330 billion to €940 billion per year. Developed since 1970 in the wake of acid rain fall that had been destroying European forests and polluting freshwaters, EU air quality policy, in combination with technological change, has contributed to reducing air pollution substantially.

Reducing smoking rates in the EU

30-09-2011

Smoking is the largest preventable cause of death in the EU, creating both direct costs to healthcare systems and indirect costs due to productivity loss.

Smoking is the largest preventable cause of death in the EU, creating both direct costs to healthcare systems and indirect costs due to productivity loss.

Municipal waste treatment methods

11-05-2011

Municipal waste treatment can have negative effects on the environment, human health and may also cause nuisance to local residents.

Municipal waste treatment can have negative effects on the environment, human health and may also cause nuisance to local residents.

The benefits of strict cut-off criteria on human health in relation to the proposal for a Regulation concerning plant protection products

15-09-2008

Executive Summary This study assesses the health benefits of strict ‘cut-off criteria’ on human health in relation to the proposal for a Regulation concerning the placing of plant protection products on the market (COM(2006) 388). The Common Position text provides that active substances classified as carcinogen, mutagen or toxic for reproduction category 1 or 2 (CMR 1 & 2), or substances considered to have endocrine disrupting properties (ED) on the basis of internationally agreed test guidelines ...

Executive Summary This study assesses the health benefits of strict ‘cut-off criteria’ on human health in relation to the proposal for a Regulation concerning the placing of plant protection products on the market (COM(2006) 388). The Common Position text provides that active substances classified as carcinogen, mutagen or toxic for reproduction category 1 or 2 (CMR 1 & 2), or substances considered to have endocrine disrupting properties (ED) on the basis of internationally agreed test guidelines, shall not be approved unless exposure to humans under realistic proposed conditions of use would be negligible. The European Parliament in its first reading amendments proposed the additional criteria that substances “considered to cause a risk of developmental neurotoxic or immunotoxic properties in humans, taking into account exposure during embryonic/foetal life and/or during childhood as well as likely combination effects” should only be approved if human exposure would be negligible. In view of the continuing debate about the criteria for approval of active substances, this study provides a scientific review of evidence concerning human health effects of plant protection products, including health benefits that could accrue from the stricter cut-off criteria. The study supports the proposal of the European Parliament that in order to ensure added protection of human health, substances considered to cause a risk of developmental neurotoxic or immunotoxic effects in humans should be added to the list of classifications that would result in non-approval of active substances, unless negligible exposure can be demonstrated. The emerging epidemiological evidence for these effects will need to be translated into classification criteria before harmonised classification for these effects can be achieved. Given that many CMR3 substances may be reclassified at a future point as CMR2, the additional proposal of the European Parliament to include CMR3 as criteria for

Εξωτερικός συντάκτης

Mark Blainey, Catherine Ganzleben, Gretta Goldenman and Iona Pratt (MILIEU Ltd. - Brussels)

Προσεχείς εκδηλώσεις

25-02-2021
Hearing on Long distance transports inside EU
Ακρόαση -
ANIT
25-02-2021
The EU-Mercosur Trade Agreement
Ακρόαση -
INTA
25-02-2021
Joint Public Hearing ‘Plastics and waste management in the circular economy’
Ακρόαση -
PETI ENVI

Εταίροι